Summary & Overview
CPT 63610: Stereotactic Spinal Cord Stimulation Lead Implantation
CPT code 63610 represents a stereotactic spinal cord stimulation lead implantation procedure in which a three-dimensional coordinate system is used to localize small targets in the spinal cord and a percutaneous needle electrode is inserted through the skin to provide targeted spinal cord stimulation. This neurosurgical, image-guided neurostimulation technique is used to manage refractory pain and certain neurologic conditions and has national relevance because of its clinical complexity, resource intensity, and implications for payer coverage and utilization management. Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find a concise overview of the clinical service and common sites of care, along with what to expect from payer coverage policies and typical billing considerations. The publication presents national-level benchmarks where available, summaries of recent policy trends affecting spinal cord stimulation implantation, and clinical context on procedural indications and care settings. Additionally, the report highlights documentation elements and coding nuances relevant to CPT code 63610, and lists common modifiers and related administrative considerations. Data not available in the input is identified where applicable.
Billing Code Overview
CPT code 63610 describes a stereotactic spinal cord stimulation lead implantation procedure in which a provider uses a three-dimensional coordinate system to locate small targets within the spinal cord and inserts a needle electrode through the skin to stimulate targeted areas. This is a neurosurgical, image-guided neurostimulation service intended to modulate spinal cord activity.
Service type: Surgical/invasive neuromodulation procedure
Typical site of service: Hospital operating room or specialized ambulatory surgical center
Clinical & Coding Specifications
Clinical Context
A 52-year-old patient with chronic, refractory neuropathic pain after prior spine surgery is evaluated for image-guided spinal cord stimulation (SCS) lead placement using a stereotactic approach. The patient has failed conservative care including medications, physical therapy, and epidural steroid injections and reports persistent radicular and axial pain limiting activities of daily living. After multidisciplinary assessment by a neurosurgeon or pain medicine specialist, the patient is scheduled for percutaneous stereotactic spinal cord stimulation trial lead placement under monitored anesthesia care in an ambulatory surgery center.
Pre-procedure workflow includes history and physical, informed consent specific to SCS trial with stereotactic guidance, review of prior imaging (MRI/CT), pre-op anesthesia assessment, and verification of implanted device compatibility (if any). In the procedure suite, three-dimensional stereotactic coordinates are registered to fluoroscopy or neuronavigation. A sterile field is prepared and a percutaneous needle electrode is inserted through the skin and advanced into the epidural space to target dorsal column sensory pathways. Intraoperative stimulation testing maps paresthesia coverage to the patient’s pain distribution. Trial leads are secured, externalized, and connected to an external stimulator for a trial period. Post-procedure orders include short-term antibiotics per local protocol, wound care, activity restrictions, and a scheduled follow-up to assess trial response. If the trial is successful, the patient may proceed to permanent implantation.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|